Literature DB >> 14966194

TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells.

Sharon M Wahl1, Jennifer Swisher, Nancy McCartney-Francis, Wanjun Chen.   

Abstract

Innate and adaptive immunity function to eliminate foreign invaders and respond to injury while enabling coexistence with commensal microbes and tolerance against self and innocuous agents. Although most often effective in accomplishing these objectives, immunologic processes are not fail-safe and may underserve or be excessive in protecting the host. Checks and balances to maintain control of the immune system are in place and are becoming increasingly appreciated as targets for manipulating immunopathologic responses. One of the most recognized mediators of immune regulation is the cytokine transforming growth factor-beta (TGF-beta), a product of immune and nonimmune cells. Emerging data have unveiled a pivotal role for TGF-beta as a perpetrator of suppression by CD4(+)CD25(+) regulatory T (Treg) cells and in apoptotic sequelae. Through its immunosuppressive prowess, TGF-beta effectively orchestrates resolution of inflammation and control of autoaggressive immune reactions by managing T cell anergy, defining unique populations of Treg cells, regulating T cell death, and influencing the host response to infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966194     DOI: 10.1189/jlb.1103539

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  55 in total

1.  Nerve growth factor modulates in vitro the expression and release of TGF-beta1 by amniotic membrane.

Authors:  Marco Coassin; Alessandro Lambiase; Alessandra Micera; Paola Tirassa; Luigi Aloe; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-13       Impact factor: 3.117

Review 2.  A role for cytokine measurement in therapeutic monitoring of immunosuppressive drugs following lung transplantation.

Authors:  P A Corris; J A Kirby
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

Review 3.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

4.  Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression.

Authors:  Amiram Ariel; Gabrielle Fredman; Yee-Ping Sun; Alpdogan Kantarci; Thomas E Van Dyke; Andrew D Luster; Charles N Serhan
Journal:  Nat Immunol       Date:  2006-10-01       Impact factor: 25.606

Review 5.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 6.  T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology.

Authors:  Gikas E Katsifis; Niki M Moutsopoulos; Sharon M Wahl
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

7.  RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.

Authors:  Audrey N Jajosky; James E Coad; Jeffrey A Vos; Karen H Martin; Jamie R Senft; Sharon L Wenger; Laura F Gibson
Journal:  Stem Cells Transl Med       Date:  2014-05-22       Impact factor: 6.940

Review 8.  Macrophage death and defective inflammation resolution in atherosclerosis.

Authors:  Ira Tabas
Journal:  Nat Rev Immunol       Date:  2009-12-04       Impact factor: 53.106

9.  Absence of alphavbeta6 integrin is linked to initiation and progression of periodontal disease.

Authors:  Farzin Ghannad; Daniela Nica; Maria I Garcia Fulle; Daniel Grenier; Edward E Putnins; Sarah Johnston; Ameneh Eslami; Leeni Koivisto; Guoqiao Jiang; Marc D McKee; Lari Häkkinen; Hannu Larjava
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

10.  Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.

Authors:  Bangwei Luo; Fuyu Han; Kai Xu; Jinsong Wang; Zongwei Liu; Zigang Shen; Jia Li; Yu Liu; Man Jiang; Zhi-Yuan Zhang; Zhiren Zhang
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.